Rivaroxaban can prevent certain arterial blood clots, but it needs to be used in conjunction with a specific medical condition. Rivaroxaban is a new type of oral anticoagulant, and the main function of this drug is to prevent as well as treat thrombotic diseases, and it also has certain therapeutic and preventive effects on certain arterial thrombotic diseases, such as pulmonary embolism. However, the prevention of some arterial thrombotic diseases requires the choice of antiplatelet drugs rather than the use of anticoagulants such as rivaroxaban. For example, arterial thrombotic diseases such as coronary heart disease, acute heart attack or cerebral infarction generally require treatment with antiplatelet drugs such as aspirin or clopidogrel. Rivaroxaban may cause adverse reactions such as bleeding and spinal/epidural hematoma. It is contraindicated for those who are at risk of bleeding, severe hepatic or renal insufficiency, coagulation disorders, pregnant and lactating women. The drug should be used under medical supervision and should not be taken on its own.